ArticleOncotarget2014
An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.
Yair Tal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ArticleOncotarget2014
Yair Tal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.